Meridian Bioscience Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$2.1M
Doctors Paid
705
Transactions
1,500
2024 Total
$439,423
Payment Breakdown by Category
Research$1.3M (63.2%)
Consulting$83,047 (4.0%)
Food & Beverage$17,689 (0.8%)
Travel$521.94 (0.0%)
Royalty/License$225.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.3M | 90 | 63.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $632,590 | 450 | 30.3% |
| Consulting Fee | $83,047 | 43 | 4.0% |
| Food and Beverage | $17,689 | 895 | 0.8% |
| Grant | $11,500 | 9 | 0.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $10,750 | 8 | 0.5% |
| Education | $6,250 | 2 | 0.3% |
| Charitable Contribution | $5,000 | 1 | 0.2% |
| Travel and Lodging | $521.94 | 1 | 0.0% |
| Royalty or License | $225.00 | 1 | 0.0% |
Payments by Type
Research
$1.3M
90 transactions
General
$767,573
1,410 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Illumigene CMV Clinical Trial Protocol | $181,084 | 0 | 10 |
| Illumigene MV Clinical Trial Protocol | $124,387 | 0 | 5 |
| Evaluating prelimary performance and setting assay cut-offs for the Revogene SMART RP assay | $103,054 | 0 | 9 |
| Premier HpSA Ultra Clinical Trial Protocol | $73,902 | 0 | 4 |
| Capillary blood study with LeadCare II Protocol | $67,407 | 0 | 5 |
| Curian HpSA Clinical Trial Protocol | $66,411 | 0 | 3 |
| Curian C. difficile Clinial Trial | $60,465 | 0 | 14 |
| Curian Shiga Toxin Clinial Trial | $55,283 | 0 | 2 |
| Curian Campy Clinical Trial | $54,838 | 0 | 3 |
| Cytomegalovirus Research Stage, Pre-Clinical Study Protocol- Specimen Collection | $50,818 | 0 | 8 |
| Curian C. difficile Clinical Trial | $41,418 | 0 | 3 |
| Clinical evaluation of the molecular-based Revogene Enteric Panel Assay | $38,564 | 0 | 4 |
| Illumigene CMV Research Agreement | $30,286 | 0 | 3 |
| Evaluating prelimary performance and setting assay cut-offs for the Revogene Enteric Panel Assay | $24,440 | 0 | 2 |
| Illumigene Group A Strep Product Study | $15,765 | 0 | 1 |
| HpSA Sample Type Comparability Study | $12,120 | 0 | 2 |
| Illumigene Group A Strep Studies | $11,900 | 0 | 1 |
| Illumigene CMV Study | $11,250 | 0 | 2 |
| IC STAT! Campy and IC STAT! EHEC Clinical Trial | $9,600 | 0 | 2 |
| Curian Cdiff Alpha Study | $9,190 | 0 | 1 |
| FLU, RSV MTA | $6,500 | 0 | 2 |
| Premier HpSA Ultra Clinical Trial | $4,800 | 0 | 1 |
| Helicobacter pylori Research Stage, Pre-Clinical Study Protocol- Specimen Collection | $200.00 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Mohammed Ali, Md, MD | Gastroenterology | Chevy Chase, MD | $58,341 | $0 |
| Dr. Peter Rappo, Md, MD | Pediatrics | West Bridgewater, MA | $13,894 | $0 |
| Dr. Jonathan Freudman, Md, MD | Internal Medicine | San Rafael, CA | $10,675 | $0 |
| Jeannette Levenstein, Md, MD | Pediatrics | Encino, CA | $5,417 | $0 |
| Dr. David Mishkin, D.o, D.O | Family Medicine | Fort Lauderdale, FL | $3,750 | $0 |
| Dr. Christopher Polage, M.d, M.D | Specialist | Sacramento, CA | $3,112 | $0 |
| Shannon Ross, M.d, M.D | Pediatric Infectious Diseases | Birmingham, AL | $3,032 | $0 |
| Cedric Pritchett, Md, MD | Student in an Organized Health Care Education/Training Program | Orlando, FL | $2,500 | $0 |
| Dr. Rosemarie Read | Pediatrics | Plainview, NY | $134.85 | $0 |
| Dr. Margaret Chalson, Md, MD | Pediatrics | Bayside, NY | $134.85 | $0 |
| Steven Perrick, Md, MD | Pediatrics | Westbury, NY | $121.41 | $0 |
| Dr. Caroline Van Vleck, M.d, M.D | Pediatrics | Washington, DC | $116.15 | $0 |
| Dr. Joanna Sexter, M.d, M.D | Pediatrics | Washington, DC | $116.13 | $0 |
| Dr. Claudia Fruin, Md, MD | Pediatrics | Salt Lake City, UT | $114.30 | $0 |
| Karen Lidoshore-Fuld, D.o, D.O | Neonatal-Perinatal Medicine | Far Rockaway, NY | $103.37 | $0 |
| Dr. Stewart Samuel | Pediatrics | Plainview, NY | $97.61 | $0 |
| Dr. Gail Goodman Kaden, Md, MD | Pediatrics | Hicksville, NY | $96.87 | $0 |
| Dr. Gregory Shifrin, Md, MD | Specialist | Brooklyn, NY | $95.96 | $0 |
| Dr. Kerry Frommer Fierstein, Md, MD | Pediatrics | Plainview, NY | $90.89 | $0 |
| Dr. Francis Palumbo, M.d, M.D | Pediatrics | Washington, DC | $90.80 | $0 |
| Kevin Hogan | Emergency Medicine | Nashville, TN | $88.51 | $0 |
| Dr. Brian Goldstein | Pediatrics | Plainview, NY | $85.19 | $0 |
| Dr. Peter Warfield, Md, Mph, MD, MPH | Pediatrics | Washington, DC | $84.82 | $0 |
| Elizabeth Issa Basch, Md, MD | Pediatrics | Westbury, NY | $84.11 | $0 |
| Dr. Kevin Hale, M.d, M.D | Family Medicine | Hot Springs, AR | $81.12 | $0 |
Ad
Top Products
- Illumigene CMV $407,015
- Revogene $166,059
Associated Products (13)
- Illumigene CMV $407,015
- Revogene $166,059
- HPSA $133,987
- C diff $101,883
- Shiga Toxin $77,816
- Leadcare II $67,407
- Campy $54,838
- Premier Platinum HpSA $49,690
- Immunocard Stat Ehec $28,479
- Illumigene GAS $28,267
- Curian Cdiff $18,720
- Illumigene Cdiff $12,769
- Immunocard STAT! HPSA $12,221
Payment Categories
- Food & Beverage $17,689
- Consulting $83,047
- Travel & Lodging $521.94
- Research $1.3M
- Royalties $225.00
About Meridian Bioscience Inc.
Meridian Bioscience Inc. has made $2.1M in payments to 705 healthcare providers, recorded across 1,500 transactions in the CMS Open Payments database. In 2024, the company paid $439,423. The top product by payment volume is Illumigene CMV ($407,015).
Payments were distributed across 62 medical specialties. The top specialty by payment amount is Gastroenterology ($60,108 to 84 doctors).
Payment categories include: Food & Beverage ($17,689), Consulting ($83,047), Research ($1.3M), Travel & Lodging ($521.94), Royalties ($225.00).
Meridian Bioscience Inc. is associated with 13 products in the CMS Open Payments database, including Illumigene CMV, Revogene, and HPSA.